Cicada Health Tech Hub Elevate 

Dr Mark Flynn
Founder, Global Edge Medtech Consulting

With a global mindset from living and working in Denmark, Sweden, UK, Italy, Argentina, Brazil, Chile, Colombia, Panama, USA, New Zealand, & China, Mark works tirelessly alongside entrepreneurs and clinical innovators to enable global market entry for medical products and services that have a clear patient centric value proposition. With experience in end-to-end translation, commercialisation, and product development, Mark can help your start-up in clearly defining the unmet market need, understanding the clinical context, building a clinical and regulatory strategy, and determining the best reimbursement pathway.

Emerald Scofield
Associate, Main Sequence Ventures

Emerald Scofield has a biotechnology background and five years of experience investing in health tech. She has been instrumental in building device and diagnostic companies from the ground up, including hands-on experience as an operations manager in a medical diagnostics startup. Emerald is passionate about advancing innovation in devices and diagnostics and is eager to help early-stage companies navigate the funding landscape and craft compelling narratives that resonate with investors.

Rebecca Dooley
Partner, Addisons

With nearly a decade’s experience in corporate and commercial law, Rebecca provides listed companies, SMEs, start ups and investors with legal advice relating to M&A and capital raising. Rebecca also provides legal advice on other corporate and commercial matters, including contracts, corporate governance and employee share plans.


Rebecca is well placed to help her clients given her thorough knowledge of Australian corporations law, contract law and the Australian Securities Exchange (ASX) Listing Rules. This knowledge is supplemented by an understanding of relevant market practice and trends, which enables Rebecca to help clients navigate both legal and commercial issues.

Prashanth Rajan
Brandon Capital

Prashanth was Senior Commercialisation Manager at UniSA Ventures, the commercialisation and investment-management arm of the University of South Australia (UniSA). Prashanth managed a portfolio of IP commercialisation projects and conducted several complex IP transactions. Prashanth was also the Operations Manager for AbRegen, a UniSA Ventures investee company, where he provided strategic leadership to the company and helped secure funding from the EB Research Partnership to further the preclinical program.

Prashanth holds a B. Technology in Bioinformatics from Sathyabama University (India) and a PhD in Biochemistry and Molecular biology, and M. Biotech (Adv) from The University of Queensland.